% | $
Quotes you view appear here for quick access.

VIVUS Inc. Message Board

  • semiequipmentgodoftheyear semiequipmentgodoftheyear Jun 17, 2013 12:12 AM Flag

    3 Humongous Health-Care Stocks This Week

    On a roll
    Avanir Pharmaceuticals (NASDAQ: AVNR ) is on a roll. After solid gains during the first week of June, the stock jumped another 19% this week.

    The primary source of investor excitement stems from a Food and Drug Administration decision announced last week to allow a faster development path for AVP-786, which is basically a newer version of Avanir's Nuedexta. Avanir will now be able to use some data from Nuedexta studies in support of its Investigational New Drug, or IND, application process for AVP-786.

    This week, Japanese investment firm Mizuho initiated coverage of Avanir with a "buy" rating. Mizuho established a price target of $10 per share, more than double the stock's current price.

    Sentiment: Strong Buy

1.22+0.10(+8.93%)Jul 1 4:00 PMEDT